These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 6281256

  • 1. Protection by superoxide dismutase, catalase, and poly(ADP-ribose) synthetase inhibitors against alloxan- and streptozotocin-induced islet DNA strand breaks and against the inhibition of proinsulin synthesis.
    Uchigata Y, Yamamoto H, Kawamura A, Okamoto H.
    J Biol Chem; 1982 Jun 10; 257(11):6084-8. PubMed ID: 6281256
    [Abstract] [Full Text] [Related]

  • 2. DNA strand breaks and poly(ADP-ribose) synthetase activation in pancreatic islets--a new aspect to development of insulin-dependent diabetes and pancreatic B-cell tumors.
    Okamoto H, Yamamoto H.
    Princess Takamatsu Symp; 1983 Jun 10; 13():297-308. PubMed ID: 6317640
    [Abstract] [Full Text] [Related]

  • 3. Effect of poly(ADP-ribose) synthetase inhibitor administration to rats before and after injection of alloxan and streptozotocin on islet proinsulin synthesis.
    Uchigata Y, Yamamoto H, Nagai H, Okamoto H.
    Diabetes; 1983 Apr 10; 32(4):316-8. PubMed ID: 6299867
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Protection by picolinamide, a novel inhibitor of poly (ADP-ribose) synthetase, against both streptozotocin-induced depression of proinsulin synthesis and reduction of NAD content in pancreatic islets.
    Yamamoto H, Okamoto H.
    Biochem Biophys Res Commun; 1980 Jul 16; 95(1):474-81. PubMed ID: 6251809
    [No Abstract] [Full Text] [Related]

  • 6. Mechanisms of streptozotocin- and alloxan-induced damage in rat B cells.
    Wilson GL, Patton NJ, McCord JM, Mullins DW, Mossman BT.
    Diabetologia; 1984 Dec 16; 27(6):587-91. PubMed ID: 6241574
    [Abstract] [Full Text] [Related]

  • 7. Induction of rat pancreatic B-cell tumors by the combined administration of streptozotocin or alloxan and poly(adenosine diphosphate ribose) synthetase inhibitors.
    Yamagami T, Miwa A, Takasawa S, Yamamoto H, Okamoto H.
    Cancer Res; 1985 Apr 16; 45(4):1845-9. PubMed ID: 2983889
    [Abstract] [Full Text] [Related]

  • 8. Streptozotocin, but not alloxan, induces DNA repair synthesis in mouse pancreatic islets in vitro.
    Sandler S, Swenne I.
    Diabetologia; 1983 Nov 16; 25(5):444-7. PubMed ID: 6228481
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Poly(ADP-ribose) synthetase inhibitors enhance streptozotocin-induced killing of insulinoma cells by inhibiting the repair of DNA strand breaks.
    Yamamoto H, Okamoto H.
    FEBS Lett; 1982 Aug 23; 145(2):298-302. PubMed ID: 6290270
    [No Abstract] [Full Text] [Related]

  • 11. Streptozotocin-induced impairment of islet B-cell metabolism and its prevention by a hydroxyl radical scavenger and inhibitors of poly(ADP-ribose) synthetase.
    Sandler S, Welsh M, Andersson A.
    Acta Pharmacol Toxicol (Copenh); 1983 Nov 23; 53(5):392-400. PubMed ID: 6318515
    [Abstract] [Full Text] [Related]

  • 12. Protective effect of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase, against streptozotocin-induced diabetes.
    Masiello P, Cubeddu TL, Frosina G, Bergamini E.
    Diabetologia; 1985 Sep 23; 28(9):683-6. PubMed ID: 2933287
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Nicotinamide does not protect islet B-cell metabolism against alloxan toxicity.
    Sandler S, Welsh M, Andersson A.
    Diabetes; 1984 Oct 23; 33(10):937-43. PubMed ID: 6237009
    [Abstract] [Full Text] [Related]

  • 15. Chemiluminescence as an index of drug-induced free radical production in pancreatic islets.
    Asayama K, English D, Slonim AE, Burr IM.
    Diabetes; 1984 Feb 23; 33(2):160-3. PubMed ID: 6229439
    [Abstract] [Full Text] [Related]

  • 16. DNA strand breaks in pancreatic islets by in vivo administration of alloxan or streptozotocin.
    Yamamoto H, Uchigata Y, Okamoto H.
    Biochem Biophys Res Commun; 1981 Dec 15; 103(3):1014-20. PubMed ID: 6460502
    [No Abstract] [Full Text] [Related]

  • 17. Protection by thymidine, an inhibitor of polyadenosine diphosphate ribosylation, of streptozotocin inhibition of insulin secretion.
    Bolaffi JL, Nagamatsu S, Harris J, Grodsky GM.
    Endocrinology; 1987 May 15; 120(5):2117-22. PubMed ID: 2952491
    [Abstract] [Full Text] [Related]

  • 18. Superoxide dismutase, catalase and scavengers of hydroxyl radical protect against the toxic action of alloxan on pancreatic islet cells in vitro.
    Grankvist K, Marklund S, Sehlin J, Täljedal IB.
    Biochem J; 1979 Jul 15; 182(1):17-25. PubMed ID: 40548
    [Abstract] [Full Text] [Related]

  • 19. Alloxan-induced DNA strand breaks in pancreatic islets. Evidence for H2O2 as an intermediate.
    Takasu N, Asawa T, Komiya I, Nagasawa Y, Yamada T.
    J Biol Chem; 1991 Feb 05; 266(4):2112-4. PubMed ID: 1989973
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms of nicotinamide and thymidine protection from alloxan and streptozocin toxicity.
    LeDoux SP, Hall CR, Forbes PM, Patton NJ, Wilson GL.
    Diabetes; 1988 Aug 05; 37(8):1015-9. PubMed ID: 2968936
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.